Energenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for ENERGI-F703DFU
KEY HIGHLIGHTS Joint development program to support process technology transfer and chemistry, manufacturing and controls (CMC) preparation for a potential new drug application (NDA) in Taiwan. The parties plan to evaluate subsequent manufacturing and commercialization licensing...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.